A dendritic cell vaccine boosts immune response and treatment outcomes for HER2-positive breast cancer.
Vous n'êtes pas connecté
A dendritic cell vaccine boosts immune response and treatment outcomes for HER2-positive breast cancer.
A dendritic cell vaccine boosts immune response and treatment outcomes for HER2-positive breast cancer.
A promising new vaccine strategy for treating a specific type of medlinkbreast cancer/medlink has been discovered by researchers. The innovative...
A promising new vaccine strategy for treating a specific type of medlinkbreast cancer/medlink has been discovered by researchers. The innovative...
Daiichi Sankyo's Datroway (datopotamab deruxtecan) has been launched in Japan for the treatment of adult patients with hormone receptor (HR) positive,...
Daiichi Sankyo's Datroway (datopotamab deruxtecan) has been launched in Japan for the treatment of adult patients with hormone receptor (HR) positive,...
Researchers in Australia are developing next-generation nanoparticles to supercharge current treatments for triple-negative breast cancer (TNBC) --...
Researchers in Australia are developing next-generation nanoparticles to supercharge current treatments for triple-negative breast cancer (TNBC) --...
Medical researchers in Japan have discovered a way to predict immune effector cell-associated neurotoxicity syndrome, a potentially life-threatening...
Shanghai, China, March 19, 2025 - Shanghai Henlius Biotech, Inc. (2696.HK) announced that the US Food and Drug Administration (FDA) has granted Orphan...
Shanghai, China, March 19, 2025 - Shanghai Henlius Biotech, Inc. (2696.HK) announced that the US Food and Drug Administration (FDA) has granted Orphan...